Cass Review – Independent Review of Gender Identity Services for Children and Young People

What is the Cass Review?

Commissioned by NHS England and NHS Improvement in 2020 and chaired by Dr. Hilary Cass, the Cass Review culminated in April 2024. It represents the most comprehensive examination to date of gender identity services for children and young people within the NHS. Over four years, it drew on systematic reviews, qualitative and quantitative research, and engagement with more than 1,000 stakeholders—including young people, families, and clinicians—to assess current services and propose reforms.

Key Findings & Recommendations

1. Evidence Gaps and Safety Concerns

  • The review identified that medical treatments—such as puberty blockers (PBs) and gender-affirming hormones (GAH)—outpaced the available evidence regarding their long-term safety and effectiveness in reducing gender dysphoria or improving mental health.
  • Understanding outcomes and developmental impacts remains insufficient, especially concerning cognitive, psychosexual, and fertility consequences

2. Holistic, Multidisciplinary Care

  • Recommended a shift toward holistic, psychosocial-first care models, including mental health and neurodevelopmental screening (e.g., for autism and ADHD)
  • Called for regional “hub” services rather than centralized models like Tavistock, enabling locally integrated, multidisciplinary care

3. Research and Regulation

  • Advocated for puberty blockers to be used only within clinical trials.
  • Emphasized rigorous application of evidence-based protocols and oversight of innovation in this sensitive healthcare area
  • Recommended services for ages 17–25 to ensure continuity and support for those transitioning to adult care.

Implementation & Outcomes

  • Service Overhaul: Tavistock clinic closed; regional hubs launched in London and Northwest England, with more underway.
  • Referral Drop: Monthly NHS referrals plunged from ~280 to 20–30 due to new referral filters and cautious approach.
  • Medical Interventions Curtailed: Puberty blockers banned indefinitely; hormone access for 16–18-year-olds now rare and tightly regulated.
  • Backlogs and Concerns: Despite new services, waiting lists remain long (~6,000), raising worries about delays, rising private treatment, and risk of youth seeking unregulated care.

Support, Praise & Criticisms

Supportive Voices:

  • Royal College of Psychiatrists praised its comprehensive, evidence-based approach and urged properly funded implementation.
  • Affirmation of Holism: Proponents argue that Cass rightly calls for integrated care that addresses co-occurring issues like trauma and neurodivergence.

Critical Voices:

  • Asserted methodological flaws—such as uncontextualized evidence, biased systematic reviews, and inadequate representation of trans experts and service users.
  • International Medical Bodies (including Australian psychiatrist associations) warned that the Review undermines existing evidence-based guidelines and fails to align with consensus approaches.
  • Trans advocates and researchers argued that necessary treatments are being withheld, with regulatory caution potentially harming youth in need.
  • Media Commentary: Some media described the Review as alarming for limiting irreversible treatments for minors without conclusive scientific backing.
  • Academic Letters from feminist and gender equality scholars accused the Review of unsound methodology and urged NHS not to enact its recommendations.

Summary Table

AspectHighlights
ScopeFirst comprehensive review of youth gender care in NHS
FindingsInsufficient evidence for PBs/GAH; need for holistic care
RecommendationsRegional hubs; PBs limited to trials; broader mental health screening
ImplementationReferral drop; new hubs; long wait times; cautious hormone policies
SupportEndorsed by Royal College; praised for evidence-based orientation
CriticismsMethodological weaknesses; exclusion of trans voices; international opposition
Risks & ConcernsBacklogs, private care bypassing NHS, potential harm from restricted access

What It Means for Policy and Advocacy

The Cass Review represents a cautious recalibration of youth gender services towards holistic, evidence-driven care. It underscores the importance of rigorous oversight and long-term monitoring of controversial treatments. For policymakers, the Review offers a model for integrating mental health, developmental assessment, and family support into care pathways—while highlighting risks of rushing irreversible interventions on uncertain evidence.

At the same time, its reception illustrates deep divides over adolescent gender care, evidentiary standards, and the weight of clinical autonomy vs. social and political sensitivity. Health systems considering similar reforms must engage diverse stakeholders, ensure transparency, and prioritize consistent rigorous data collection to support both safety and access.

Follow the link to download The Cass Review Final Report

https://cass.independent-review.uk/home/publications/final-report